SOAT1 and neoplasm: The reported GSC resistance to radiation and conventional chemotherapeutics, including temozolomide, are currently ascribed to a number of factors: signaling pathways involved in tumor cell contacts and tumor–stroma interactions, including the Wnt/β-catenin, the Notch, PI3K, and JAK/STAT pathways [17].